| One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™ (NCT02939118) | ViaCyte | 2016-11-07 |
| The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. (NCT01320345) | University of Sydney | 2016-11-03 |
| Cohort Study of Patients With Type 1 Diabetes (NCT03610984) | Second Xiangya Hospital of Central South University | 2016-10-01 |
| The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus (NCT02882737) | Hvidovre University Hospital | 2016-09-01 |
| Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research (NCT04096794) | Second Xiangya Hospital of Central South University | 2016-09-01 |
| A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus (NCT02897219) | Astellas Pharma Inc | 2016-08-29 |
| Type 1 Diabetes Extension Study (NCT02734277) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-08-18 |
| Remote Monitoring of Diabetes in Young Children With Type 1 Diabetes (NCT02848261) | Stanford University | 2016-08-15 |
| T1DM Immunotherapy Using Polyclonal Tregs + IL-2 (NCT02772679) | Jeffrey Bluestone | 2016-08-01 |
| Accuracy, Satisfaction and Usability of a FGM System Among Children and Adolescents Attending a Diabetes Summer Camp (NCT03368586) | University of Lausanne Hospitals | 2016-07-02 |
| Bigfoot Biomedical Clinical Research Center (CRC) Trial (NCT02849288) | Bigfoot Biomedical Inc. | 2016-07-01 |
| Prevalence and Incidence of Complications of Type One Diabetes in PUne At a Tertiary Care CentRE (NCT03069196) | Kem Hospital, Pune, India | 2016-06-10 |
| Visualizing Beta Cells After Islet Transplantation (NCT03785236) | Radboud University Medical Center | 2016-06-06 |
| Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1) (NCT02794155) | Diasome Pharmaceuticals | 2016-06-01 |
| The Effects of Type 1 Diabetes Mellitus and Increased Weight on Gut Microbiome and Urine Metabolome Profiles in Children (NCT02938806) | University of California, San Diego | 2016-06-01 |
| A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus (NCT02688933) | Sanofi | 2016-05-05 |
| Clinical Features and Prevalence of Asymptomatic Peripheral Artery Disease in Patients With Type 1 Diabetes Mellitus (NCT02910271) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2016-05-01 |
| A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia (NCT02635243) | Sanofi | 2016-04-01 |
| A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM (NCT02739906) | Adocia | 2016-04-01 |
| A Qualitative Study on CSII in Children and Adolescents Having Type 1 Diabetes (NCT03066284) | Dasman Diabetes Institute | 2016-03-14 |
| iOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes (NCT02980627) | Duke University | 2016-03-01 |
| Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus (NCT02715193) | REMD Biotherapeutics, Inc. | 2016-03-01 |
| Pancreatic Islet Transplantation in the Anterior Chamber of the Human Eye - a Pilot Study (NCT02916680) | University Hospital, Basel, Switzerland | 2016-03-01 |
| Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon (NCT02516150) | Massachusetts General Hospital | 2016-03-01 |
| Continue Glucose Monitoring Before Insulin Pump (NCT02813421) | Children's Hospital Los Angeles | 2016-03-01 |
| Isometric Handgrip Exercise -MRI in Children and Adolescents (NCT03506711) | University of Lausanne Hospitals | 2016-02-01 |
| At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation (NCT02705053) | Sansum Diabetes Research Institute | 2016-02-01 |
| Effects of Gluten Free Diet on Type 1 Diabetes Mellitus in Children (NCT02605564) | Loma Linda University | 2016-01-19 |
| Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients (NCT03463564) | University of Campania Luigi Vanvitelli | 2016-01-01 |
| BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study (NCT02662842) | Becton, Dickinson and Company | 2016-01-01 |
| Prevention of Hypoglycemia After Exercise Using Closed Loop System in Children and Adolescents With Type 1 Diabetes (NCT02657083) | University of Ljubljana, Faculty of Medicine | 2016-01-01 |
| Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients (NCT02666430) | Mylan Inc. | 2015-12-01 |
| A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients (NCT02625636) | Sanofi | 2015-12-01 |
| The Effect of Cocoa Flavanol on the BOLD Response and Cognitive Function in Type 1 Diabetes (NCT03452605) | Vrije Universiteit Brussel | 2015-11-20 |
| Study of Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With TD1 Melitis (NCT02204397) | Jewish General Hospital | 2015-11-01 |
| Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion (NCT02603510) | Sanofi | 2015-11-01 |
| The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM (NCT02582814) | AstraZeneca | 2015-10-26 |
| Mindfulness for Adolescents With Type 1 Diabetes (NCT03942471) | Duquesne University | 2015-10-14 |
| The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM (NCT02582840) | AstraZeneca | 2015-10-01 |
| Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes (NCT02745808) | Chinese Academy of Sciences | 2015-09-01 |
| Diabetes Care Transformation: Diabetes Data Registry and Intensive Remote Monitoring (NCT02596204) | Children's Hospitals and Clinics of Minnesota | 2015-09-01 |
| Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus (NCT02529449) | Astellas Pharma Inc | 2015-09-01 |
| A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog® (NCT02562313) | Adocia | 2015-09-01 |
| How to be Safe With Alcoholic Drinks in Diabetes (NCT02518022) | Kinderkrankenhaus auf der Bult | 2015-09-01 |
| Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM (NCT02558491) | Daniel Chernavvsky, MD | 2015-09-01 |
| Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes (NCT02579148) | Leilei Zhu | 2015-09-01 |
| Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus (NCT02500979) | AstraZeneca | 2015-08-17 |
| Aralast NP in Islet Transplant (NCT02520076) | University of Alberta | 2015-08-01 |
| Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes (NCT02518945) | University at Buffalo | 2015-08-01 |
| To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus (NCT02528396) | Adocia | 2015-08-01 |
| PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM) (NCT02485327) | Mannkind Corporation | 2015-07-01 |
| Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus (NCT02514954) | Adocia | 2015-07-01 |
| Dose-ranging Study in Patients With Type 1 Diabetes Mellitus (NCT02459899) | Lexicon Pharmaceuticals | 2015-07-01 |
| Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus (NCT02470637) | Mannkind Corporation | 2015-06-01 |
| MPC Versus PID for Closed Loop Insulin Delivery (NCT02438670) | Sansum Diabetes Research Institute | 2015-05-01 |
| Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy (NCT02421510) | Lexicon Pharmaceuticals | 2015-05-01 |
| Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C (NCT02383940) | Lexicon Pharmaceuticals | 2015-04-01 |
| T1DM Clinical Onset and Progression in Paediatric Population (NCT03547440) | University of Turin, Italy | 2015-03-18 |
| Tocilizumab (TCZ) in New-onset Type 1 Diabetes (NCT02293837) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-03-12 |
| Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus (NCT03920397) | Universidade Federal do Rio de Janeiro | 2015-03-01 |
| User Performance and System Accuracy Evaluations Using Glucose Adjustment (NCT02374879) | LifeScan | 2015-02-01 |
| Shared Medical Decision Making in Pediatric Diabetes (NCT02496156) | Nemours Children's Clinic | 2015-02-01 |
| Fr1da Early Diagnosis and Care of Type 1 Diabetes (NCT04039945) | Helmholtz Zentrum München | 2015-02-01 |
| Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes (NCT02372253) | University of Alabama at Birmingham | 2015-02-01 |
| High-Intensity Exercise and Endothelial Function in Type 1 Diabetes(HIIT-T1D) (NCT03451201) | Hospital de Clinicas de Porto Alegre | 2015-01-01 |
| Teleconsultation in Type 1 Diabetes Mellitus (NCT02812498) | Niguarda Hospital | 2015-01-01 |
| Acceptability and Feasibility of an ACT-Based Group to Improve Diabetes Self-Management (NCT02256293) | Duke University | 2015-01-01 |
| The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia (NCT02308293) | Radboud University Medical Center | 2015-01-01 |
| Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes (NCT02360254) | University of Padova | 2015-01-01 |
| Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects (NCT02408705) | Medical University of Graz | 2015-01-01 |
| A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001) (NCT02269735) | Merck Sharp & Dohme LLC | 2014-11-26 |
| Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (NCT02268214) | AstraZeneca | 2014-11-11 |
| Insulin Therapy and Lipoproteins' Profile in Type 1 Diabetes. (NCT02306005) | Poznan University of Medical Sciences | 2014-11-01 |
| Type 1 Diabetes, Immunology, Genetics & Endogenous Insulin Production (NCT03490773) | Royal Devon and Exeter NHS Foundation Trust | 2014-11-01 |
| Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine (NCT02273180) | Sanofi | 2014-10-01 |
| Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump in Children (NCT02179281) | University of Ljubljana, Faculty of Medicine | 2014-10-01 |
| An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT) (NCT02232698) | Abbott Diabetes Care | 2014-09-01 |
| Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes (NCT02175732) | University of California, San Francisco | 2014-09-01 |
| Allogeneic Islet Cells Transplanted Onto the Omentum (NCT02213003) | Rodolfo Alejandro | 2014-09-01 |
| A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus (NCT02239354) | ViaCyte | 2014-09-01 |
| Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus (NCT02201199) | Sanofi | 2014-08-01 |
| The Effect of Hypoglycaemia on Brain Lactate Accumulation and Cerebral Blood Flow (NCT02146404) | Radboud University Medical Center | 2014-08-01 |
| Pilot Study: Intensive Education in a Residential Camp Setting for Families of Young Children With Type 1 Diabetes (NCT02432586) | University of Texas Southwestern Medical Center | 2014-07-01 |
| Feasibility Study of PID Versus MPC and HMS (NCT01987206) | Sansum Diabetes Research Institute | 2014-07-01 |
| An Evaluation of Internet-based Carbohydrate Counting Education for Adolescents With Type 1 Diabetes (NCT02462785) | The Hospital for Sick Children | 2014-07-01 |
| Hyaluronidase Effect on Infusion Set Life (NCT02199028) | Stanford University | 2014-07-01 |
| Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus (NCT02206568) | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 2014-06-01 |
| Hybrid Artificial Pancreas in Home Setting (NCT02153190) | University Hospital, Montpellier | 2014-05-01 |
| Treatment of Diabetic Neuropathy With Liraglutide (NCT02138045) | Aalborg University Hospital | 2014-05-01 |
| Physical Activity in Children With Type 1 Diabetes Study (NCT02144337) | University of Nottingham | 2014-05-01 |
| Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes. (NCT02109315) | Anna Cruceta | 2014-05-01 |
| Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study (NCT02057211) | Uppsala University Hospital | 2014-04-01 |
| Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus (NCT02093221) | Grifols Therapeutics LLC | 2014-03-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005) (NCT02059174) | Merck Sharp & Dohme LLC | 2014-02-10 |
| Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes (NCT02068638) | Insel Gruppe AG, University Hospital Bern | 2014-02-01 |
| Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus (NCT02044848) | Novartis Pharmaceuticals | 2014-02-01 |
| T and B Cell Responses in Autoimmune Diseases (NCT01947036) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-01 |
| Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus (NCT01781975) | University of California, San Francisco | 2014-01-01 |
| Safety and Efficacy of Overnight Closed Loop in Children With Type 1Diabetes Mellitus in Luxembourg (NCT02099409) | Centre Hospitalier du Luxembourg | 2014-01-01 |
| Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM (NCT02204839) | Northumbria University | 2014-01-01 |